Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab

In the randomized, placebo-controlled FREEDOM study of women aged 60 to 90 years with postmenopausal osteoporosis, treatment with denosumab once every 6 months for 36 months significantly reduced hip and new vertebral fracture risk by 40% and 68%, respectively. To gain further insight into this effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Keaveny, Tony M, McClung, Michael R, Genant, Harry K, Zanchetta, Jose R, Kendler, David, Brown, Jacques P, Goemaere, Stefan, Recknor, Chris, Brandi, Maria L, Eastell, Richard, Kopperdahl, David L, Engelke, Klaus, Fuerst, Thomas, Radcliffe, Hoi-Shen, Libanati, Cesar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238810/
https://www.ncbi.nlm.nih.gov/pubmed/23794225
http://dx.doi.org/10.1002/jbmr.2024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238810/
https://www.ncbi.nlm.nih.gov/pubmed/23794225
http://dx.doi.org/10.1002/jbmr.2024

Ejemplares similares